Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

BACKGROUND: Platelet-derived growth factor receptor (PDGFR) signaling has been directly implicated in pediatric high-grade gliomagenesis. This study evaluated the safety and tolerability of crenolanib, a potent, selective inhibitor of PDGFR-mediated phosphorylation, in pediatric patients with high-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinkle, Christopher L, Broniscer, Alberto, Chiang, Jason, Campagne, Olivia, Huang, Jie, Orr, Brent A, Li, Xiaoyu, Patay, Zoltan, Zhang, Jinghui, Baker, Suzanne J, Merchant, Thomas E, Jain, Vinay, Onar-Thomas, Arzu, Stewart, Clinton F, Wetmore, Cynthia, Gajjar, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717895/
https://www.ncbi.nlm.nih.gov/pubmed/34993482
http://dx.doi.org/10.1093/noajnl/vdab179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717895/
https://www.ncbi.nlm.nih.gov/pubmed/34993482
http://dx.doi.org/10.1093/noajnl/vdab179

Ejemplares similares